Hypertension Perspective

 
 
  • Resistant Hypertension: What Not to Reach For   An expert shares what's best to try fourth-line for resistant hypertension, as well as what to avoid.
  • The 'Triple G' Agonist for Obesity Management: 5 Things to Know Anti-obesity medication (AOM) can be an invaluable tool for individuals who are unable to sustain long-term weight loss through lifestyle changes alone. Recent groundbreaking findings from a phase 2 trial have shown immense potential for a new AOM.
  • New ACG Guidelines Offer Key Advice on Acute Liver Failure Dr Nancy Reau speaks with Dr Alexandra Shingina, lead author behind the guidelines, about the special considerations required for managing this rare condition.
  • It's Not Easy Saying No to Weight Loss Drugs Misuse of some GLP-1 receptor agonists is already being reported. How do you handle the patient who wants the drug but doesn't qualify for it?
  • Beyond A1c: Implementing the New ESC 2023 Guidelines Recent evidence for newer diabetes therapies has prompted a shift from a glucocentric approach to the management of type 2 diabetes to one of overall cardiovascular risk reduction.
  • SGLT2i in Acute Heart Failure, The Earlier The Better?   Ileana Piña interviews Zachary Cox, PharmD, about the DICTATE-AHF trial on the initiation of the SGLT2 inhibitor, dapagliflozin, early in acute heart failure decompensation.
  • Obesity and Nutrition Highlights From ESC 2023   Key studies in obesity and nutrition from ESC 2023 support prevention and treatment of obesity in cardiovascular risk reduction and promotion of unprocessed foods to prevent heart disease.
  • Sep 15 2023 This Week in Cardiology   Reader feedback, imaging in the cath lab, AF ablation to relieve anxiety, and some possible help in hypertension are the topics John Mandrola, MD, discusses in this week's podcast.
  • The Case for 'Pleasure Hygiene' Pebble Kranz, MD, discusses how clinicians can encourage "pleasure hygiene" to improve the lives of their patients with chronic conditions.
  • Glucose Management in the New ADA Guidelines Dr Domenica Rubino highlights therapeutic updates for glucose management in T2D in the updated American Diabetes Association guidelines.
  • Chronic Coronary Disease: The Latest Recommendations   Dr Neil Skolnik reviews the latest guidelines for managing patients with stable coronary artery disease in primary care.
  • HYP 2023 Read clinically focused news coverage of key developments from HYP 2023
  • ERS 2023 – Navigating Chronic Cough in Primary Care "When it comes to chronic cough, general practitioners often feel lost," said an expert at the European Respiratory Society Congress held in Milan, Italy.
  • Blood Test for Severe Preeclampsia Will Save Lives The Food and Drug Administration recently approved a blood test that will predict, with 96% accuracy, whether a pregnant person will develop severe preeclampsia within 2 weeks.
  • Change Makers: Elcin Barker Ergun on Healthcare Renaissance WebMD Chief Medical Officer John Whyte, MD, MPH, speaks with Elcin Barker Ergun, CEO of the Menarini Group, in Florence, Italy, about what they believe to be a new renaissance in healthcare.
  • Episode 10: Approach to Cardiotoxicity: Art That Needs More Science   Drs Michelle Kittleson and Bonnie Ky discuss the field of cardio-oncology and how cancer treatment-related cardiotoxicity can be prevented, detected, and treated to improve the quality of cancer survivorship.
  • Alarming Surge in Liquid Nicotine Toxicity in Kids   Drs Robert Glatter and Ryan Marino discuss the hidden dangers, symptoms, interventions, and urgent need for awareness in this alarming public health issue with nearly 7000 reported incidents.
  • Semaglutide's Big STEP in HFpEF With Obesity   The GLP-1 receptor agonist semaglutide led to weight loss and improved quality of life in patients with heart failure with preserved ejection fraction and obesity.
  • Aug 25 2023 This Week in Cardiology   GLP-1 agonists in HFpEF, DOACs for subclinical AF, renal denervation, and the matter of remaining in the profession are the topics John Mandrola, MD, discusses in this week’s podcast.
  • 'Patients Fail' Despite Benefits of Sustained Weight Loss Obesity needs to be treated like every other chronic noncommunicable disease rather than as personal responsibility, contends Yoni Freedhoff, MD.
  • S2 Episode 3: Does Your Patient Have IgA Nephropathy?   Experts Drs Matthew A. Sparks and Dana V. Rizk discuss the pathology, presentation, and management of IgA nephropathy. Looking for the latest on clinical trials and approved treatments? Tune in!